Swiss National Bank Has $2.36 Million Stock Holdings in Tilray Inc (NASDAQ:TLRY)

Swiss National Bank grew its stake in Tilray Inc (NASDAQ:TLRY) by 10.2% during the fourth quarter, HoldingsChannel.com reports. The firm owned 1,776,638 shares of the company’s stock after buying an additional 164,600 shares during the period. Swiss National Bank’s holdings in Tilray were worth $2,363,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Verdence Capital Advisors LLC acquired a new position in Tilray in the fourth quarter valued at about $29,000. Ameritas Advisory Services LLC bought a new stake in shares of Tilray in the 4th quarter valued at about $32,000. Newman Dignan & Sheerar Inc. raised its position in shares of Tilray by 61.9% in the 4th quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company’s stock valued at $35,000 after acquiring an additional 10,000 shares during the period. Jones Financial Companies Lllp boosted its stake in Tilray by 125.7% during the 4th quarter. Jones Financial Companies Lllp now owns 31,725 shares of the company’s stock worth $42,000 after acquiring an additional 17,670 shares during the last quarter. Finally, KBC Group NV grew its holdings in Tilray by 75.9% during the fourth quarter. KBC Group NV now owns 38,332 shares of the company’s stock valued at $51,000 after purchasing an additional 16,539 shares during the period. 9.35% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group increased their target price on shares of Tilray from $2.00 to $3.00 and gave the stock a “buy” rating in a report on Monday, January 13th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $2.70.

Tilray Stock Up 9.0 %

Shares of TLRY stock opened at $0.71 on Friday. The company has a market capitalization of $669.49 million, a price-to-earnings ratio of -2.38 and a beta of 2.13. Tilray Inc has a 12-month low of $0.58 and a 12-month high of $2.97. The firm has a fifty day moving average of $0.87 and a 200-day moving average of $1.27. The company has a quick ratio of 1.58, a current ratio of 2.54 and a debt-to-equity ratio of 0.10.

Tilray (NASDAQ:TLRY) last issued its quarterly earnings results on Friday, January 10th. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.07). The firm had revenue of $210.90 million during the quarter, compared to the consensus estimate of $216.34 million. Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. As a group, equities research analysts predict that Tilray Inc will post -0.2 earnings per share for the current fiscal year.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.